NEOsphere Biotechnologies

NEOsphere Biotechnologies accelerates TPD drug discovery at every stage with pioneering high-throughput proteomics. Our global proteomics and interactomics platforms rapidly and efficiently screen entire libraries for novel degraders for disease-relevant targets, and support lead optimization through fast, proteome-wide analysis of SAR, selectivity, potency, kinetics, and efficacy in native cells. Global ubiquitinomics reveals compound-induced ubiquitination and ternary complex formation at unparalleled depth, validating degraders and delivering unique starting points for innovative therapies.